Fitch Rates Indian Pharma As "Stable" For 2010 But Will Be Concerned Over Large Debt-led Capital Expenditure Plans
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - For 2010, the Indian pharmaceutical market will continue to expand aided by a sales growth of 11-12 percent, as more and more people see a rise in their purchasing power and health insurance spreads out more prominently, indicated Fitch Ratings - known for its credit risk rating analysis - in its outlook report for the Indian pharmaceutical industry